You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 44TH ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Merkel Cell Carcinoma

Prognosis and Management

Anusak Yiengpruksawan, MD; Daniel G. Coit, MD; Howard T. Thaler, PhD; Carlos Urmacher, MD; William K. Knapper, MD

Arch Surg. 1991;126(12):1514-1519.


Abstract

• Seventy patients with Merkel cell carcinoma were treated at Memorial Sloan-Kettering Cancer Center between 1969 and 1989. The overall estimated 5-year survival rate was 64%. Factors predictive of improved survival included head and neck site and negative lymph nodes at presentation. Local recurrence was seen in 18 patients (26%) and did not correlate with patient-, tumor-, or treatment-related variables. Nine patients with local recurrence (50%) were free of disease following aggressive reoperation. Regional nodes were involved at some point during the course of the disease in forty-six patients (66%). Regional lymph node involvement was apparent within 2 years of diagnosis in 40 (87%) of 46 patients in whom it occurred. Systemic disease was nearly uniformly preceded by the appearance of nodal metastases and was uniformly fatal regardless of subsequent therapy. This suggests an orderly "cascade" pattern of spread for this tumor, in which elective regional lymph node dissection may be justified. Our recommendations for treatment include a wide excision of the primary tumor and either elective or early therapeutic regional node dissection. The role of adjuvant radiotherapy or chemotherapy remains unproven.

(Arch Surg. 1991;126:1514-1519)



Author Affiliations

From the Departments of Surgery (Drs Yiengpruksawan, Coit, and Knapper), Epidemiology and Biostatistics (Dr Thaler), and Pathology (Dr Urmacher), Memorial Sloan-Kettering Cancer Center, New York, NY.


Footnotes

Accepted for publication October 5, 1991.

Presented at the 44th Annual Cancer Symposium of the Society of Surgical Oncology, Orlando, Fla, March 26, 1991.

Reprint requests to Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (Dr Coit).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patients With Merkel Cell Carcinoma Tumors <= 1.0 cm in Diameter Are Unlikely to Harbor Regional Lymph Node Metastasis
Stokes et al.
JCO 2009;27:3772-3777.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma Arising in the Ear Canal
Petkovic et al.
INT J SURG PATHOL 2008;16:337-340.
ABSTRACT  

Adjuvant Radiation Therapy Is Associated With Improved Survival in Merkel Cell Carcinoma of the Skin
Mojica et al.
JCO 2007;25:1043-1047.
ABSTRACT | FULL TEXT  

Merkel cell cancer of the skin
Pectasides et al.
Ann Oncol 2006;17:1489-1495.
ABSTRACT | FULL TEXT  

Management of merkel cell carcinoma: what we know.
Alam
Arch Dermatol 2006;142:771-774.
FULL TEXT  

Reliability of Sentinel Lymph Node Biopsy for Regional Staging of Head and Neck Merkel Cell Carcinoma
Schmalbach et al.
Arch Otolaryngol Head Neck Surg 2005;131:610-614.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution
Allen et al.
JCO 2005;23:2300-2309.
ABSTRACT | FULL TEXT  

High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study--TROG 96:07
Poulsen et al.
JCO 2003;21:4371-4376.
ABSTRACT | FULL TEXT  

Imaging of Merkel Cell Carcinoma
Nguyen and McCullough
RadioGraphics 2002;22:367-376.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma
Goessling et al.
JCO 2002;20:588-598.
FULL TEXT  

Chemotherapy in Neuroendocrine/Merkel Cell Carcinoma of the Skin: Case Series and Review of 204 Cases
Tai et al.
JCO 2000;18:2493-2499.
ABSTRACT | FULL TEXT  

Merkel-Cell Carcinomas in Patients Treated with Methoxsalen and Ultraviolet A Radiation
Lunder and Stern
NEJM 1998;339:1247-1248.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.